L-asparaginase (ASNase) is a major treatment regimen for ALL by depleting plasma asparagine and glutamine, while glutamine synthetase was found to be remarkedly elevated in CAAs in ALL. This evidence concerns the gene GLUL and acute lymphoblastic leukemia.